Carcinoma of the lower uterine segment (LUS): Clinicopathological characteristics and association with Lynch syndrome

Kenta Masuda, Kouji Banno, Megumi Yanokura, Yusuke Kobayashi, Iori Kisu, Arisa Ueki, Asuka Ono, Hiroyuki Nomura, Akira Hirasawa, Nobuyuki Susumu, Daisuke Aoki

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Endometrial cancer arises from the uterine body and fundus in many cases, but can also originate from the lower region of the uterine body through the upper region of the cervix. Such tumors are referred to as carcinoma of the lower uterine segment (LUS) or isthmus, and account for 3-6.3% of all cases of endometrial cancer. This relatively low incidence has permitted performance of only small-scale studies, but the clinical and pathological characteristics of carcinoma of the LUS in all these reports have differed from those of other endometrial cancers. Generally, endometrial cancer is classified into estrogen-dependent endometrioid adenocarcinoma (designated as type I), and non-endometrioid types that are less associated with estrogen and include poorly differentiated adenocarcinoma (type II). In some reports, carcinoma of the LUS has been found to have type II characteristics. Carcinoma of the LUS has also been associated with Lynch syndrome, a hereditary disease with frequent development of colorectal, endometrial, and ovarian cancers. Lynch syndrome is thought to be induced by mismatch repair gene mutation. The frequency of Lynch syndrome in cases of general endometrial cancer is 1-2%. In contrast, the frequency in patients with carcinoma of the LUS is much higher, with up to 29% of cases diagnosable with Lynch syndrome and a high frequency of hMSH2 mutation found in one study. This suggests that further investigation of the clinical and pathological characteristics of carcinoma of the LUS and the association with Lynch syndrome is required through performance of a large-scale survey.

Original languageEnglish
Pages (from-to)25-29
Number of pages5
JournalCurrent Genomics
Volume12
Issue number1
DOIs
Publication statusPublished - 2011

Fingerprint

Hereditary Nonpolyposis Colorectal Neoplasms
Endometrial Neoplasms
Carcinoma
Estrogens
Endometrioid Carcinoma
Body Regions
Inborn Genetic Diseases
DNA Mismatch Repair
Mutation Rate
Cervix Uteri
Ovarian Neoplasms
Colorectal Neoplasms
Adenocarcinoma
Mutation
Incidence
Genes
Neoplasms

Keywords

  • DNA mismatch repair gene
  • Endometrial cancer
  • hMSH2
  • Lower uterine segment
  • Lynch syndrome

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Carcinoma of the lower uterine segment (LUS) : Clinicopathological characteristics and association with Lynch syndrome. / Masuda, Kenta; Banno, Kouji; Yanokura, Megumi; Kobayashi, Yusuke; Kisu, Iori; Ueki, Arisa; Ono, Asuka; Nomura, Hiroyuki; Hirasawa, Akira; Susumu, Nobuyuki; Aoki, Daisuke.

In: Current Genomics, Vol. 12, No. 1, 2011, p. 25-29.

Research output: Contribution to journalArticle

Masuda, Kenta ; Banno, Kouji ; Yanokura, Megumi ; Kobayashi, Yusuke ; Kisu, Iori ; Ueki, Arisa ; Ono, Asuka ; Nomura, Hiroyuki ; Hirasawa, Akira ; Susumu, Nobuyuki ; Aoki, Daisuke. / Carcinoma of the lower uterine segment (LUS) : Clinicopathological characteristics and association with Lynch syndrome. In: Current Genomics. 2011 ; Vol. 12, No. 1. pp. 25-29.
@article{6f671332f2c7475bb4d62d92759153bb,
title = "Carcinoma of the lower uterine segment (LUS): Clinicopathological characteristics and association with Lynch syndrome",
abstract = "Endometrial cancer arises from the uterine body and fundus in many cases, but can also originate from the lower region of the uterine body through the upper region of the cervix. Such tumors are referred to as carcinoma of the lower uterine segment (LUS) or isthmus, and account for 3-6.3{\%} of all cases of endometrial cancer. This relatively low incidence has permitted performance of only small-scale studies, but the clinical and pathological characteristics of carcinoma of the LUS in all these reports have differed from those of other endometrial cancers. Generally, endometrial cancer is classified into estrogen-dependent endometrioid adenocarcinoma (designated as type I), and non-endometrioid types that are less associated with estrogen and include poorly differentiated adenocarcinoma (type II). In some reports, carcinoma of the LUS has been found to have type II characteristics. Carcinoma of the LUS has also been associated with Lynch syndrome, a hereditary disease with frequent development of colorectal, endometrial, and ovarian cancers. Lynch syndrome is thought to be induced by mismatch repair gene mutation. The frequency of Lynch syndrome in cases of general endometrial cancer is 1-2{\%}. In contrast, the frequency in patients with carcinoma of the LUS is much higher, with up to 29{\%} of cases diagnosable with Lynch syndrome and a high frequency of hMSH2 mutation found in one study. This suggests that further investigation of the clinical and pathological characteristics of carcinoma of the LUS and the association with Lynch syndrome is required through performance of a large-scale survey.",
keywords = "DNA mismatch repair gene, Endometrial cancer, hMSH2, Lower uterine segment, Lynch syndrome",
author = "Kenta Masuda and Kouji Banno and Megumi Yanokura and Yusuke Kobayashi and Iori Kisu and Arisa Ueki and Asuka Ono and Hiroyuki Nomura and Akira Hirasawa and Nobuyuki Susumu and Daisuke Aoki",
year = "2011",
doi = "10.2174/138920211794520169",
language = "English",
volume = "12",
pages = "25--29",
journal = "Current Genomics",
issn = "1389-2029",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Carcinoma of the lower uterine segment (LUS)

T2 - Clinicopathological characteristics and association with Lynch syndrome

AU - Masuda, Kenta

AU - Banno, Kouji

AU - Yanokura, Megumi

AU - Kobayashi, Yusuke

AU - Kisu, Iori

AU - Ueki, Arisa

AU - Ono, Asuka

AU - Nomura, Hiroyuki

AU - Hirasawa, Akira

AU - Susumu, Nobuyuki

AU - Aoki, Daisuke

PY - 2011

Y1 - 2011

N2 - Endometrial cancer arises from the uterine body and fundus in many cases, but can also originate from the lower region of the uterine body through the upper region of the cervix. Such tumors are referred to as carcinoma of the lower uterine segment (LUS) or isthmus, and account for 3-6.3% of all cases of endometrial cancer. This relatively low incidence has permitted performance of only small-scale studies, but the clinical and pathological characteristics of carcinoma of the LUS in all these reports have differed from those of other endometrial cancers. Generally, endometrial cancer is classified into estrogen-dependent endometrioid adenocarcinoma (designated as type I), and non-endometrioid types that are less associated with estrogen and include poorly differentiated adenocarcinoma (type II). In some reports, carcinoma of the LUS has been found to have type II characteristics. Carcinoma of the LUS has also been associated with Lynch syndrome, a hereditary disease with frequent development of colorectal, endometrial, and ovarian cancers. Lynch syndrome is thought to be induced by mismatch repair gene mutation. The frequency of Lynch syndrome in cases of general endometrial cancer is 1-2%. In contrast, the frequency in patients with carcinoma of the LUS is much higher, with up to 29% of cases diagnosable with Lynch syndrome and a high frequency of hMSH2 mutation found in one study. This suggests that further investigation of the clinical and pathological characteristics of carcinoma of the LUS and the association with Lynch syndrome is required through performance of a large-scale survey.

AB - Endometrial cancer arises from the uterine body and fundus in many cases, but can also originate from the lower region of the uterine body through the upper region of the cervix. Such tumors are referred to as carcinoma of the lower uterine segment (LUS) or isthmus, and account for 3-6.3% of all cases of endometrial cancer. This relatively low incidence has permitted performance of only small-scale studies, but the clinical and pathological characteristics of carcinoma of the LUS in all these reports have differed from those of other endometrial cancers. Generally, endometrial cancer is classified into estrogen-dependent endometrioid adenocarcinoma (designated as type I), and non-endometrioid types that are less associated with estrogen and include poorly differentiated adenocarcinoma (type II). In some reports, carcinoma of the LUS has been found to have type II characteristics. Carcinoma of the LUS has also been associated with Lynch syndrome, a hereditary disease with frequent development of colorectal, endometrial, and ovarian cancers. Lynch syndrome is thought to be induced by mismatch repair gene mutation. The frequency of Lynch syndrome in cases of general endometrial cancer is 1-2%. In contrast, the frequency in patients with carcinoma of the LUS is much higher, with up to 29% of cases diagnosable with Lynch syndrome and a high frequency of hMSH2 mutation found in one study. This suggests that further investigation of the clinical and pathological characteristics of carcinoma of the LUS and the association with Lynch syndrome is required through performance of a large-scale survey.

KW - DNA mismatch repair gene

KW - Endometrial cancer

KW - hMSH2

KW - Lower uterine segment

KW - Lynch syndrome

UR - http://www.scopus.com/inward/record.url?scp=79951705385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951705385&partnerID=8YFLogxK

U2 - 10.2174/138920211794520169

DO - 10.2174/138920211794520169

M3 - Article

C2 - 21886452

AN - SCOPUS:79951705385

VL - 12

SP - 25

EP - 29

JO - Current Genomics

JF - Current Genomics

SN - 1389-2029

IS - 1

ER -